OXFORD, UK - Oxford BioDynamics Plc (AIM: OBD), a biotechnology company, has announced the successful outcomes of a clinical study for its EpiSwitch® Colorectal No-Stool Test (NST), which has been ...

Immutep Ltd ( ($AU:IMM) ) has provided an announcement. Immutep Ltd has released a corporate presentation to update stakeholders on its business ...

Learn more about whether Blueprint Medicines Corporation or Zai Lab Limited is a better investment based on AAII's A+ ...

The new sorghum varieties provide a climate-smart alternative grain for food science, breweries and dairy farmers ...

Bristol-Plymouth Regional Technical School sent seven students to the hospital after they experienced light-headedness and headaches in a chemistry lab.

United Therapeutics Corp. announced Feb. 4. that it will start a trial in mid-2025 with six patients who have end-stage renal disease. These patients, who have been on dialysis for at least six months ...

The Food and Drug Administration has given two biotechnology companies approval for clinical trials that will transplant ...

MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the stocks that nosedived in January, going from $42.98 to $32.75 on ...

COUR Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies designed ...

The life sciences industry has a significant impact on the North Carolina economy. Using data from NCBiotech’s life sciences ...

We’re already seeing the benefits of joining IBioIC as we set our sights on scaling up and broadening our impact” – Sander ...